CVKD · CIK 0001937993 · operating
Cadrenal Therapeutics, Inc. (CVKD) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $20 million, Cadrenal Therapeutics, Inc. is a micro-cap company. The stock currently trades at $8.58, up 1.11% today, with a 52-week range of $4.91–$21.70.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-8.73 | $-8.73 | -1308.1% | |
| 2023 | $-0.62 | $-0.62 | +27.1% | |
| 2022 | $-0.85 | $-0.85 | — |